Canaan Partners VII LLC
CIK 1514133 · last filed 2018-10-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TLRA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
STE. 250
WESTPORT, CT 06880
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Telaria, Inc. (TLRA) Delisted | 10%+ Owner | 5,406,405 | — | — | -$10.77M | 10 | 2018-10-24 |
| LendingClub Corp (LC) Delisted | Director | 186,735 | $19.21 | $3.59M | $0 | 6 | 2016-11-18 |
| Telaria, Inc. (TRMR) Delisted | Director | 7,565,959 | $5.02 | $37.98M | -$848.2K | 5 | 2016-08-18 |
| MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Director | 536,380 | $0.55 | $295.0K | $9.84M | 5 | 2016-08-02 |
| CHIMERIX INC (CMRX) Delisted | Director | 4,983,088 | $8.54 | $42.56M | $0 | 2 | 2014-01-23 |
Recent Filings · Page 3 of 3
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-02-04 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-11-12 | LendingClub Corp (LC) Delisted | Other (J) | −4,600,000 | $0 | EDGAR |
| 2015-11-05 | LendingClub Corp (LC) Delisted | Other (J) | −4,400,000 | $0 | EDGAR |
| 2015-06-19 | LendingClub Corp (LC) Delisted | Other (J) | −30,433,674 | $0 | EDGAR |
| 2014-10-02 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-08-06 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Mixed | +4,922,796 | $10.00M | EDGAR |
| 2014-01-23 | CHIMERIX INC (CMRX) Delisted | Other (J) | −1,740,558 | $0 | EDGAR |
| 2013-04-18 | CHIMERIX INC (CMRX) Delisted | Exer (X) | +423,566 | $3.08M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.